Cure My Disease

Don't miss your cure!

 Log in / Sign up

New 3D mapping and dye technique could make lung cancer surgery safer and more precise

NCT ID NCT03953144

Recruiting now Disease control Sponsor: St. Joseph's Healthcare Hamilton Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated May 16, 2026 · Updated 14 times

Summary

This study tests a new way to perform lung cancer surgery for people with early-stage non-small cell lung cancer. Surgeons will use a 3D computer model (Synapse 3D) and a special dye (ICG) to see exactly which part of the lung needs to be removed. The goal is to remove only the diseased segment, sparing healthy lung tissue, and to see if this approach is safe and works well. About 32 participants will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Josephs Healthcare Hamilton

    RECRUITING

    Hamilton, Ontario, L8N 4A6, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER PRIMARY NEOPLASM